Axitinib (AG-013736) in combination with FOLFOX and bevacizumab (Bev) in patients (pts) with metastatic solid tumors: A phase I study

被引：4

作者：

Abhyankar, V. V.

Sharma, S.

Trowbridge, R. C.

Robles, R. L.

Tarazi, J. C.

Kim, S.

Tortorici, M.

Hee, B.

Burgess, R. E.

机构：

[1] Eastern Carolina Internal Med, Pollocksville, NC USA

[2] Nevada Canc Inst, Las Vegas, NV USA

[3] St Francis Canc Care Ctr, Indianapolis, IN USA

[4] Bay Area Canc Res Grp, Concord, CA USA

[5] Pfizer Global Res & Dev, San Diego, CA USA

来源：

关键词：

D O I：

10.1200/jco.2008.26.15_suppl.4112

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4112

引用

页数：1